Clinical Trial

Pain Related to Local Anesthetic Administration for Nexplanon Placement

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 6, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This research study is being conducted to see if using buffered lidocaine for Nexplanon placement decreases pain associated with administering local anesthesia compared to unbuffered lidocaine, which is currently used in clinic. Lidocaine is used to stop pain in the nerve fibers in order to decrease pain at the time of the procedure. We want to find out if using buffered lidocaine will decrease discomfort at the time of receiving local anesthesia for Nexplanon insertion.
Trial Details
NCT Number NCT07008222
Lead Sponsor University of California, San Diego
Conditions Pain Related to Local Anesthetic Administration for Nexplanon Placement
Enrollment 68 participants
Start Date 2025-06
Primary Completion 2026-01 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-06-06